General medical oncology

Leuven researchers have developed a new way to make immunotherapy work better for melanoma patients that are currently not reacting to their treatment. By targeting a specific type of melanoma cells, the reaction to immunotherapy can be improved.

Leuven researchers collaborated on a brand new gamma-secretase inhibitor for rare connective tissue tumours. "It is the first time that we were able to find a medicine against aggressive desmoid tumours with convincing clinical evidence."

For certain types of chemotherapy, scalp cooling and hand-foot cooling can limit or even prevent side effects such as hair loss and nerve damage. UZ Leuven and Think Pink have requested NIHDI to invest in accessible care. And succesfully so: as 1 January 2023 these costs are being reimbursed.